College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement

Drug and Alcohol Dependence

Volumn 69, Issue 3, 2003, Pages 215-232

  Zacny, James ^a   Bigelow, George ^b   Compton, Peggy ^c   Foley, Kathleen ^d   Iguchi, Martin ^e   Sannerud, Christine ^f  

^a UNIVERSITY OF CHICAGO   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e RAND CORPORATION   (United States)

^f Drug Enforcement Administration   (United States)

Author keywords

Abuse liability; Analgesia; Dependence; Epidemiology; Opioid; Pain; Prescription

Indexed keywords

COCAINE; DIAMORPHINE; OPIATE;

COCAINE DEPENDENCE; HEALTH PROGRAM; HEROIN DEPENDENCE; HIGH RISK POPULATION; HUMAN; OPIATE ADDICTION; PAIN; PHOBIA; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 0037375098     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00003-6     Document Type: Review

References (69)

1. Abreu M.E., Bigelow G.E., Fleisher L., Walsh S.L. Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology. 154:2001;76-84.
2. The use of opioids for the treatment of chronic pain: a consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin. J. Pain. 13:1997;6-8.
3. Diagnostic and Statistical Manual of Mental Disorders-IV. 1994;American Psychiatric Association, Washington, DC.
4. Angarola R.T., Wray S.D. Legal impediments to cancer pain treatment. Adv. Pain Res. Ther. 11:1989;213-231.
5. Brady, J.V., Lukas, S.E. (Eds.), 1984. Testing Drugs for Abuse Liability and Dependence Potential: Methods used in Animals and Man. US Government Printing Office, NIDA Research Monograph No. 52, DHHS Publication No. (ADM) 84-1332 Washington, DC.
6. Breitbart W., Rosenfeld B.D., Passik S.D., McDonald M.V., Thaler H., Portenoy R.K. The undertreatment of pain in ambulatory AIDS patients. Pain. 65:1996;243-249.
7. Cami J., Bigelow G.E., Griffiths R.R., Drummond D.C. Special issue: clinical testing of drug abuse liability. Br. J. Addict. 86:1991;1525-1652.
8. Cicero T.J., Adams E.H., Geller A., Inciardi J.A., Munoz A., Schnoll S.H., Senay E.C., Woody G.E. A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend. 57:1999;7-22.
9. Cleeland C.S., Gonin R., Hatfield A.K., Edmonson J.H., Blum R.H., Stewart J.A., Pandya K.J. Pain and its treatment in outpatients with metastatic cancer. New Engl. J. Med. 330:1994;592-596.
10. D'Amore J., Hung O., Chiang W., Goldfrank L. The epidemiology of the homeless population and its impact on an urban emergency department. Acad. Emerg. Med. 8:2001;1051-1055.
11. de Wit H., Dudish S., Ambre J. Subjective and behavioral effects of diazepam depend on its rate of onset. Psychopharmacology. 112:1993;324-330.
12. DeSio J.M., Bacon D.R., Peer G., Lema M.J. Intravenous abuse of transdermal fentanyl therapy in a chronic pain patient. Anesthesiology. 79:1993;1139-1141.
13. Drayer R.A., Henderson J., Reidenberg M. Barriers to better pain control in hospitalized patients. J. Pain Symptom Manage. 17:1999;434-440.
14. Epstein, J.F., 2002. Substance Dependence, Abuse, and Treatment: Findings From the 2000 National Household Survey on Drug Abuse. (NHSDA Series A-16, DHHS Publication No. SMA 02-3642). Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
15. Federation of State Medical Boards of the United States, Inc., 1998. Model Guidelines for the Use of Controlled Substances for the Treatment of Pain. Euless, Texas.
16. Fishbain D.A., Rosomoff H.L., Rosomoff R.S. Drug abuse, dependence, and addiction in chronic pain patients. Clin. J. Pain. 8:1992;77-85.
17. Fishman S.M., Bandman T.B., Edwards A., Borsook D. The opioid contract in the management of chronic pain. J. Pain Symptom Manage. 18:1999;27-37.
18. Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J. Urban Health: Bull. New York Acad. Med. 78:2001;214-235.
19. Gardner J.R., Sandhu G. The stigma and enigma of chronic non-malignant back pain (CNMBP) treated with long-term opioids (LTO). Contemp. Nurse. 6:1997;61-66.
20. Graber M.A., Bergus G., Dawson J.D., Wood G.B., Levy B.T., Levin I. Effect of a patient's psychiatric history on physicians' estimation of probability of disease. J. Gen. Intern. Med. 15:2000;204-206.
21. Griffiths R.R., Balster R.L. Opioids: similarity between evaluations of subjective effects and animal self-administration results. Clin. Pharmacol. Ther. 25:1979;611-617.
22. Gfoerer J., Wright D., Kopstein A. Prevalence of youth substance use: the impact of methodological differences between two national surveys. Drug Alcohol Depend. 47:1997;19-30.
23. Hill C.S. Jr. Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. J. Pain Symptom Manage. 11:1996;287-298.
24. Hill C.S., Fields W.S. Drug treatment of cancer pain in a drug-oriented society. Adv. Pain Res. Ther. 11:1989;1-380.
25. Institute of Medicine, 1996. Pathways of Addiction. Opportunities in Drug Abuse Research. National Academy Press, Washington, DC.
26. Jasinski D.R. Assessment of the abuse potential of morphine-like drugs (methods used in man). Martin W.R. Handbook of Experimental Pharmacology. Vol. 45/1. Drug Addiction I. Morphine, Sedative/Hypnotic and Alcohol Dependence. 1977;197-258 Springer Verlag, Berlin.
27. Johnson S.H. Disciplinary actions and pain relief: analysis of the Pain Relief Act. J. Law Med. Ethics. 24:1996;319-327.
28. Johnston, L.D., O'Malley, P.M., Bachman, J.G., 2002. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2001. (NIH Publication No. 02-5105). National Institute on Drug Abuse, Bethesda, MD.
29. Joranson D.E., Gilson A.M. Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies. J. Am. Pharm. Assoc. 41:2001;213-220.
30. Joranson D.E., Ryan K.M., Gilson A.M., Dahl J.L. Trends in medical use and abuse of opioid analgesics. J. Am. Med. Assoc. 283:2000;1710-1714.
31. Joranson D.E., Gilson A.M., Dahl J.L., Haddox J.D. Pain management, controlled substances, and state medical board policy: a decade of change. J. Pain Symptom Manage. 23:2002;138-147.
32. Marquardt K.A., Tharratt R.S. Inhalation abuse of fentanyl patch. J. Toxicol. Clin. Toxicol. 32:1994;75-78.
33. Martino A.M. In search of a new ethic for treating patients with chronic pain: What can medical boards do. J. Law Med. Ethics. 26:1998;332-334.
34. McCaffery M., Ferrell B.R. Nurses' knowledge of pain assessment and management: how much progress have we made. J. Pain Symptom Manage. 14:1997;175-188.
35. Morgan J.P., Pleet D.L. Opiophobia in the United States: the undertreatment of severe pain. Morgan J.P., Kagan D.V. Society and Medication: Conflicting Symbols for Prescribers and Patients. 1983;313-326 Lexington Press, Lexington, MA.
36. Morrison R.S., Wallenstein S., Natale D.K., Senzel R.S., Huang L.L. We don't carry that' - failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. New Engl. J. Med. 342:2000;1023-1026.
37. Musto D.F. Historical perspectives. Lowinson J.H., Ruiz P., Millman R.B., Langrod J.G. Substance Abuse: a Comprehensive Textbook. third ed :1997;1-10 Williams & Wilkins, Baltimore, MD.
38. Effective medical treatment of opiate addiction. J. Am. Med. Assoc. 280:1998;1936-1943.
39. National Institute on Drug Abuse, 2001. Prescription drugs: abuse and addiction. NIDA research report. NIH Publication No. 01-4881, Rockville, MD.
40. Office of National Drug Control Policy, 1997. What America's users spend on illegal drugs. 1988-1995, US Department of Justice, Rockville, MD.
41. Perry S., Heidrich G. Management of pain during debridement: a survey of US burn units. Pain. 13:1982;267-280.
42. Portenoy R. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J. Pain Symptom Manage. 11:1996;203-217.
43. Portenoy R.K., Foley K.M. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 25:1986;171-186.
44. Purucker M., Swann W. Potential for duragesic patch abuse. Ann. Emerg. Med. 35:2000;314.
45. Regier D.A., Myers J.K., Kramer M., Robins L.N., Blazer D.G., Hough R.L., Eaton W.W., Locke B.Z. The NIMH epidemiological catchment area program. Historical context, major objectives, and study population characteristics. Arch. Gen. Psychiatry. 41:1984;934-941.
46. Roset P.N., Farre M., dela Torre R., Mas M., Menoyo E., Hernandez C., Cami J. Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend. 64:2001;285-298.
47. Savage S.R. Addiction in the treatment of pain: significance, recognition, and management. J. Pain Symptom Manage. 8:1993;265-278.
48. Savage S.R. Long-term opioid therapy: assessment of consequences and risks. J. Pain Symptom Manage. 11:1996;274-286.
49. Schuster C.R. Does treatment of cancer pain with narcotics produce junkies. Adv. Pain Res. Ther. 11:1989;1-4.
50. Scimeca M.M., Savage S.R., Portenoy R., Lowinson J. Treatment of pain in methadone-maintained patients. Mt. Sinai J. Med. 67:2000;412-422.
51. Senay E.C. Substance Abuse Disorders in Clinical Practice. second ed :1998;Norton, New York.
52. Silverman K., Wong C.J., Higgins S.T., Brooner R.K., Montoya I.D., Contoreggi C., Umbricht-Schneiter A., Schuster C.R., Preston K.L. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 41:1996;157-165.
53. Substance Abuse and Mental Health Services Administration (SAMHSA), 2001a. Office of Applied Studies, Summary of Findings from the 2000 National Household Survey on Drug Abuse. NHSDA Series H-13, DHHS Publication No. (SMA) 01-3549, Rockville, MD.
54. Substance Abuse and Mental Health Services Administration (SAMHSA), 2001b. Office of Applied Studies, Treatment Episode Data Set (TEDS): 1994-1999. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-14, DHHS Publication No. (SMA) 01-3550, Rockville, MD.
55. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002a. Office of Applied Studies, Results From the 2001 National Household Survey on Drug Abuse: Volume II. Technical Appendices and Selected Data Tables. (Office of Applied Studies, NHSDA Series H-18, DHHS Publication No. SMA 02-3759), Rockville, MD.
56. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002b. Office of Applied Studies, Emergency Department Trends from the Drug Abuse Warning Network, Final Estimates 1994-2001, DAWN Series D-21, DHHS Publication No. (SMA) 02-3635, Rockville, MD.
57. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002c. Office of Applied Studies, Results From the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. (Office of Applied Studies, NHSDA Series H-17, DHHS Publication No. SMA 02-3758), Rockville, MD.
58. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002d. Office of Applied Studies, Treatment Episode Data Set (TEDS). Based on administrative data reported by the states to TEDS through 9.30.2002. Office of Applied Studies, http://www.dasis.samhsa.gov/webt/NewMapv1.htm, accessed November 25, 2002.
59. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002e. Office of Applied Studies, Results From the 2001 National Household Survey on Drug Abuse: Volume III. Detailed Tables. (Office of Applied Studies, NHSDA Series H-19, DHHS Publication No. SMA 02-3760), Rockville, MD.
60. Substance Abuse and Mental Health Services Administration (SAMHSA), 2002f. Office of Applied Studies, 2000 Detailed NHSDA Tables, http://www.samhsa.gov/oas/nhsda/2kdetailedtabs/Vol_1_Part_1/sect1v1.htm#1. 107b, accessed November 25, 2002.
61. Sutton M., Atweh G.F., Cashman T.D., Davis W.T. Resolving conflicts: misconceptions and myths in the care of the patient with sickle cell disease. Mt. Sinai J. Med. 66:1999;282-285.
62. Turk D.C., Brody M.C. What position do APS's physicians take on chronic opioid therapy. Am. Pain. Soc. Bull. 2:1992;1-5.
63. US General Accounting Office, 1998. Drug abuse treatment. Data limitations affect the accuracy of national and state estimates of need. US General Accounting Office, Washington, DC.
64. Weinstein S.M., Laux L.F., Thornby J.I., Lorimor R.J., Hill C.S. Jr, Thorpe D.M., Merrill J.M. Physicians' attitudes toward pain and the use of opioid analgesics: results of a survey from the Texas Cancer Pain Initiative. South Med. J. 93:2000;479-487.
65. Weissman D.E., Haddox J.D. Opioid pseudoaddiction - an iatrogenic syndrome. Pain. 36:1989;363-366.
66. Weissman D.E., Joranson D.E., Hopwood M.B. Wisconsin physicians' knowledge and attitudes about opioid analgesic regulations. Wis. Med. J. 90:1991;671-675.
67. World Health Organization, 1992. International Statistical Classification of Diseases and Related Health Problems, tenth rev. World Health Organization, Geneva, Switzerland.
68. World Health Organization, 2000. Achieving Balance in National Opioids Control Policy. Guidelines for Assessment. World Health Organization, Geneva, Switzerland.
69. Zhukovsky D.S., Gorowski E., Hausdorff J., Napolitano B., Lesser M. Unmet analgesic needs in cancer patients. J. Pain Symptom Manage. 10:1995;113-119.